Septic serum induces glucocorticoid resistance and modifies the expression of glucocorticoid isoforms receptors: a prospective cohort study and in vitro experimental assay
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Background: A protective role for glucocorticoid therapy in animal models of sepsis was shown many decades ago. In human sepsis, there is new interest in glucocorticoid therapy at a physiological dose after reports of improved response to vasopressor drugs and decreased mortality in a selected group of patients. However, other reports have not confirmed these results. Cellular glucocorticoid resistance could explain a possible cause of that. To evaluate this hypothesis, we evaluated the expression of glucocorticoid receptor beta, the dominant negative isoform of glucocorticoid receptor, in peripheral mononuclear cells of septic patients and the effect of serum septic patients over glucocorticoid receptor expression and glucocorticoid sensitivity in immune cells culture. Methods: A prospective cohort study and an in vitro experimental study with matched controls were developed. Nine patients with septic shock and nine healthy controls were prospectively enrolled. Mononuclear cells and serum samples were obtained from the patients with sepsis on admission to the Intensive Care Unit and on the day of discharge from hospital, and from healthy volunteers matched by age and sex with the patients. Glucocorticoid receptor alpha and beta expression from patients and from immune cell lines cultured in the presence of serum from septic patients were studied by western blot. Glucocorticoid sensitivity was studied in control mononuclear cells cultured in the presence of serum from normal or septic patients. A statistical analysis was performed using a Mann-Whitney test for non-parametric data and analysis of variance for multiple comparison; P < 0.05 was considered significant. Results: The patients' glucocorticoid receptor beta expression was significantly higher on admission than on discharge, whereas the alpha receptor was not significantly different. In vitro, septic serum induced increased expression of both receptors in T and B cells in culture, with a greater effect on receptor beta than the control serum. Septic serum induced glucocorticoid resistance in control mononuclear cells. Conclusion: There is a transient increased expression of glucocorticoid receptor beta in mononuclear cells from septic patients. Serum from septic patients induces cell glucocorticoid resistance in vitro. Our findings support a possible cell glucocorticoid resistance in sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clinical studies in patients with septic shock [79,80] and ARDS [7] have provided evidence of an association between the degree of intracellular glucocorticoid resistance, disease severity, and mortality.”
From Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a multispecialty task force of the society of critical care medicine (SCCM) and the European society of intensive care medicine (ESICM) (2017) · cites this paper as [80]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Sepsis is also characterized by an increased expression of the GR isoform GR-β in circulating cells, resulting in an imbalance between GRα and GRβ [80,83].”
In the citing paper
“and increased GR-β (dominant negative activity on GR-induced transcription) [80,83,84].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503 · cited 2×
“Sepsis is a leading cause of death in intensive care units (ICUs) around the world [1].”
BackgroundDellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869 · cited 1×
“The actions of GCs are mediated by their receptor (GR), which acts as a ligand-dependent transcription factor [29-31].”
BackgroundBone, R. C., Fisher, C. J., Clemmer, T. P., Slotman, G. J., Metz, C. A., Balk, R. A., & The Methylprednisolone Severe Sepsis Study Group (1987) · New England Journal of Medicine · doi:10.1056/nejm198709103171101 · Cited by 1,440 · cited 1×
“The early approach of high dose GCs for sepsis therapy was abandoned when the potential benefits initially reported [9-11] could not be replicated, and higher mortality associated with secondary infections was suggested [12,13].”
BackgroundDombrovskiy, V. Y., Martin, A. A., Sunderram, J., & Paz, H. L. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000261890.41311.e9 · Cited by 1,249
Annane, D. (2000) · JAMA · doi:10.1001/jama.283.8.1038 · Cited by 1,000 · cited 2×
“A renewed interest in GC therapy in sepsis, at what has been termed a physiological dose, was seen after reports of improved response to vasopressor drugs and decreased mortality in selected groups of patients who had an inadequate response to adrenocorticotropin hormone (ACTH) (defined as an increase in total plasma…”
Background
Cited by
Annane, D., Pastores, S. M., Arlt, W., Balk, R. A., Beishuizen, A., Briegel, J., Carcillo, J., Christ-Crain, M., Cooper, M. S., Marik, P. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4914-x · Cited by 220
“Sepsis is also characterized by an increased expression of the GR isoform GR-β in circulating cells, resulting in an imbalance between GRα and GRβ [80, 83].”
Backgroundde Jong, M. F., Molenaar, N., Beishuizen, A., & Groeneveld, A. J. (2015) · Critical Care · doi:10.1186/s13054-014-0721-8 · Cited by 150
“Finally, we did not know or evaluate the potentially interfering phenomenon of steroid resistance in critical illness [30].”
BackgroundAdrenal function and dysfunction in critically ill patients
Téblick, A., Peeters, B., Langouche, L., & den Berghe, G. V. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0185-7 · Cited by 173
The Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity
Lockett, J., Inder, W. J., & Clifton, V. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae008 · Cited by 135
Glucocorticoids in Sepsis: To Be or Not to Be
Vandewalle, J., & Libert, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01318 · Cited by 132
Annane, D., Pastores, S. M., Arlt, W., Balk, R. A., Beishuizen, A., Briegel, J., Carcillo, J., Christ-Crain, M., Cooper, M. S., Marik, P. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002724 · Cited by 117
Endocrine Responses to Critical Illness: Novel Insights and Therapeutic Implications
Boonen, E., & Van den Berghe, G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4115 · Cited by 105
“Finally, because glucocorticoid sensitivity likely varies among individuals (95) and among cell types in critically ill patients (68, 81, 83) and glucocorticoid treatment may down-regulate GR- via induction of miR-124, the dosing issue is further complicated (96).”
BackgroundGlucocorticoid resistance as a major drive in sepsis pathology
Dendoncker, K., & Libert, C. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.04.002 · Cited by 85
“reported a transient increase of the dominant negative GRβ in PBMCs during sepsis [186].”
BackgroundMorris, G., Berk, M., Maes, M., Carvalho, A. F., & Puri, B. K. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1498-1 · Cited by 85
New insights into the controversy of adrenal function during critical illness
Boonen, E., Bornstein, S. R., & Van den Berghe, G. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00224-7 · Cited by 77
Dominance of the strongest: Inflammatory cytokines versus glucocorticoids
Dejager, L., Vandevyver, S., Πέττα, Ι., & Libert, C. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.12.006 · Cited by 85
“Also, a role for GRb was postulated in steroid resistant ulcerative colitis [149], sepsis [150] and rheumatoid arthritis patients [151].”
Backgroundden Berghe, G. V., Téblick, A., Langouche, L., & Gunst, J. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104284 · Cited by 76
Critical Illness–induced Corticosteroid Insufficiency: What It Is Not and What It Could Be
Téblick, A., Gunst, J., & den Berghe, G. V. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac201 · Cited by 71
Cohen, J., Pretorius, C. J., Ungerer, J. P. J., Cardinal, J., Blumenthal, A., Presneill, J., Gatica-Andrades, M., Jarrett, P., Lassig-Smith, M., Stuart, J., et al. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001633 · Cited by 58
“Increased expression of the GRβ splice variant has been proposed as a potential mechanism for acquired glucocorticoid resistance in critical illness (4, 5, 20).”
BackgroundVardas, K., Ilia, S., Sertedaki, A., Charmandari, E., Briassouli, E., Goukos, D., Apostolou, K., Psarra, K., Botoula, E., Tsagarakis, S., et al. (2017) · Intensive Care Medicine Experimental · doi:10.1186/s40635-017-0123-8 · Cited by 58
“Septic serum induces the expression of not only hGRα but also of hGRβ in both T and B cells in culture, supporting a possible GC resistance of specific cell subpopulations in sepsis [9].”
BackgroundJenniskens, M., Weckx, R., Dufour, T., Perre, S. V., Pauwels, L., Derde, S., Téblick, A., Güiza, F., den Berghe, G. V., & Langouche, L. (2018) · Endocrinology · doi:10.1210/en.2018-00344 · Cited by 51
The glucocorticoid receptor and cortisol levels in pediatric septic shock
Alder, M. N., Opoka, A. M., & Wong, H. R. (2018) · Critical Care · doi:10.1186/s13054-018-2177-8 · Cited by 40
Adrenocortical Stress Response during the Course of Critical Illness
Peeters, B., Langouche, L., & Van den Berghe, G. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170022 · Cited by 39
“Evidence from animal and human studies indicate that, besides alternative splicing of the GR, also GR expression, GR affinity and GR translocation are regulated and could be tissue-specific during critical illness (15, 63, 116, 141).”
Langouche, L., Téblick, A., Gunst, J., & den Berghe, G. V. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad021 · Cited by 47
Cortisol metabolism in critical illness: implications for clinical care
Boonen, E., & den Berghe, G. V. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000066 · Cited by 47
Decreased glucocorticoid receptor expression during critical illness
Vassiliou, A. G., Floros, G., Jahaj, E., Stamogiannos, G., Gennimata, S., Vassiliadi, D. A., Tsagarakis, S., Tzanela, M., Ilias, Ι., Orfanos, S. E., et al. (2019) · European Journal of Clinical Investigation · doi:10.1111/eci.13073 · Cited by 28
Boonen, E., & den Berghe, G. V. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1098 · Cited by 30
Cohen, J., Blumenthal, A., Cuéllar-Partida, G., Evans, D. M., Finfer, S. R., Li, Q., Ljungberg, J. K., Myburgh, J., Peach, E., Powell, J. E., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06464-5 · Cited by 28
Téblick, A., Dyck, L. V., Aerde, N. V., Perre, S. V., Pauwels, L., Derese, I., Debaveye, Y. A., Wouters, P. J., Vanhorebeek, I., Langouche, L., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104057 · Cited by 31
Glucocorticoid Treatment Strategies in Liver Failure
Ye, C., Li, W., Li, L., & Zhang, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.846091 · Cited by 35
Novel insights in endocrine and metabolic pathways in sepsis and gaps for future research
Téblick, A., Gunst, J., Langouche, L., & den Berghe, G. V. (2022) · Clinical Science · doi:10.1042/cs20211003 · Cited by 24
Vassiliou, A. G., Stamogiannos, G., Jahaj, E., Botoula, E., Floros, G., Vassiliadi, D. A., Ilias, Ι., Tsagarakis, S., Tzanela, M., Orfanos, S. E., et al. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110656 · Cited by 22
Goodwin, J. E., Feng, Y., Velazquez, H., Zhou, H., & Sessa, W. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108126 · Cited by 19
“Recent work has also suggested that the presence of the b isoform of the glucocorticoid receptor may be responsible for glucocorticoid resistance under some conditions, including in human septic shock [21,22].”
BackgroundFredrick, F. C., Meda, A. K. R., Singh, B. P., & Jain, R. (2024) · Acute and Critical Care · doi:10.4266/acc.2024.00647 · Cited by 22
“Additionally, serum obtained from septic patients induces glucocorticoid resistance in cell cultures, suggesting a potential mechanism for cell-level resistance to glucocorticoids in sepsis [35].”
BackgroundGlucocorticoid and mineralocorticoid receptor expression in critical illness: A narrative review
Vassiliou, A. G., Athanasiou, N., Vassiliadi, D. A., Jahaj, E., Keskinidou, C., Kotanidou, Α., & Dimopoulou, I. (2021) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v10.i4.102 · Cited by 21
Vassiliadi, D. A., Vassiliou, A. G., Ilias, Ι., Tsagarakis, S., Kotanidou, Α., & Dimopoulou, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111473 · Cited by 18
“In a different study, a transient increase in GCR-β mRNA expression was seen in sepsis, and, moreover, serum from the septic patients could induce GC resistance in vitro [73].”
BackgroundEndocrinology of the Stress Response During Critical Illness
Marik, P. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00076-5 · Cited by 21
Glucocorticoid-Induced Leucine Zipper: A Promising Marker for Monitoring and Treating Sepsis
He, Y., Xu, J., Sun, M., Fang, X., Peng, Z.-K., Pan, S., Zhou, T., Wang, Y., & Shang, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.606649 · Cited by 16
Glucocorticoid Receptor Expression in Peripheral WBCs of Critically Ill Children*
Shibata, A. R. O., Troster, E. J., & Wong, H. R. (2015) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000407 · Cited by 15
“Further relevant investigation could also evaluate if there are drugs previously studied in vitro (41, 52) Figure 3.”
Molina, M. L., Guerrero, J., Cidlowski, J. A., Gatica, H., & Annelise Goecke, S. (2017) · Journal of Inflammation · doi:10.1186/s12950-017-0169-0 · Cited by 17
“esis through 10% polyacrylamide gels and transferred to nitrocellulose membranes as previously described [18].”
Self-citationWentworth, B. J., Schliep, M. K., Novicoff, W. M., Siragy, H. M., Geng, C. X., & Henry, Z. H. (2022) · Liver International · doi:10.1111/liv.15473 · Cited by 15
Poupouzas, G. I., Lotsios, N. S., Vrettou, C. S., Issaris, V., Keskinidou, C., Papavassiliou, K. A., Halioti, A., Botoula, E., Tzanela, M., Papavassiliou, A. G., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05628-9 · Cited by 12
“Most studies have reported generalized GC resistance, mainly in sepsis, on the basis of single-cell analyses [18–20].”
Ilias, Ι., Vassiliou, A. G., Keskinidou, C., Vrettou, C. S., Orfanos, S. E., Kotanidou, Α., & Dimopoulou, I. (2023) · Biomedicines · doi:10.3390/biomedicines11071801 · Cited by 19
The role of glucocorticoid receptor (GR) polymorphisms in human erythropoiesis.
Varricchio, L., & Migliaccio, A. R. (2014) · Europe PMC (PubMed Central) · Cited by 16
Ramsay, S. D., Nenke, M. A., Meyer, E. J., Torpy, D. J., & Young, R. L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1508848 · Cited by 9
The nature of the GRE influences the screening for GR-activity enhancing modulators
Dendoncker, K., Timmermans, S., Looveren, K. V., Cauwer, L. D., Bosscher, K. D., & Libert, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181101 · Cited by 9
GILZ in sepsis: “Poor is the pupil who does not surpass his master”
Vandewalle, J., & Libert, C. (2020) · European Journal of Immunology · doi:10.1002/eji.202048582 · Cited by 11
Salton, F., Confalonieri, P., Meduri, G. U., Mondini, L., Trotta, L., Barbieri, M., Bozzi, C., Torregiani, C., Lerda, S., Bellan, M., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16070924 · Cited by 8
Meduri, G. U., & Chrousos, G. P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-817558-3.00012-3 · Cited by 8
Cela, E., Patterson, E. K., Gill, S. E., Cepinskas, G., & Fraser, D. D. (2025) · Clinical and Translational Science · doi:10.1111/cts.70161 · Cited by 12
Adjunctive Steroid Therapy for Treatment of Pediatric Septic Shock
Zimmerman, J. J. (2017) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2017.06.010 · Cited by 7
Li, J., Xie, M., Yu, Y., Tang, Z., Hang, C., & Li, C. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108660 · Cited by 7
Glucocorticoid administration in sepsis and septic shock: time for a paradigm change?
Antonucci, E., Fiaccadori, E., Taccone, F. S., & Vincent, J. (2014) · PubMed · Cited by 8
Prolonged glucocorticoid treatment in ARDS: Pathobiological rationale and pharmacological principles
Meduri, G. U., Confalonieri, M., Chaudhuri, D., Rochwerg, B. N., & Meibohm, B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-817558-3.00019-6 · Cited by 11
Steroid responses in sepsis: some novel thinking that may provide new insight
Deutschman, C. S. (2013) · Critical Care · doi:10.1186/cc12723 · Cited by 5
Lipopolysaccharide Stress Induces Cryptic Exon Splice Variants of the Human Glucocorticoid Receptor
Green, T. L., Leventhal, S. M., Lim, D., Cho, K., & Greenhalgh, D. G. (2019) · Shock · doi:10.1097/shk.0000000000001318 · Cited by 6
Anti, N. A. O., Gheorghe, C. P., Deming, D. D., Adeoye, O. O., Zhang, L., & Mata‐Greenwood, E. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1587891 · Cited by 6
Lotsios, N. S., Vrettou, C. S., Poupouzas, G. I., Chalioti, A., Keskinidou, C., Pratikaki, M. E., Giannopoulou, V., Kotanidou, Α., Vassiliadi, D. A., Dimopoulou, I., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1414785 · Cited by 6
Endocrine interventions in the intensive care unit
Téblick, A., Langouche, L., & den Berghe, G. V. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819973-2.00028-9 · Cited by 4
New concepts to further unravel adrenal insufficiency during critical illness
Boonen, E., & den Berghe, G. V. (2016) · Cited by 3
Meduri, G. U. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2691-6206 · Cited by 3
“GILZexpressionremainsstableinitiallybutincreasesafter 5 to 7 days, suggesting adaptive GR activity 20 GILZ upregulation may partially compensate for reduced GR α -mediated transcription”
Kállai, B. M., Csöndes, J., Kiss, G., Bodrogi, L., Rónai, Z., & Mészáros, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-03451-0 · Cited by 3
Marik, P. E. (2014) · Springer eBooks · doi:10.1007/978-3-319-11020-2_39 · Cited by 3
Alshamsi, F. E., Alkaabi, S., Alfadli, M., Alshkeili, N. A. N. S., Alhosani, S. M. I., & Agha, A. (2025) · Diagnostics · doi:10.3390/diagnostics15202588 · Cited by 2
Ghosh, S., Mukherjee, G., & Bishayi, B. (2026) · Chronobiology International · doi:10.1080/07420528.2026.2628053 · Cited by 1
“They also have examined the GR-β, but low overall expression in peripheral blood cells prevented them for meaningful interpretation of the data and concluded that GR-β is a dominant negative receptor (Guerrero et al. 2013; Cohen et al. 2016).”
Corticosteroid Treatment in Septic Shock
Liu, J., Xing, Q., Pan, X., Zhang, S., Chen, D., & Annane, D. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2694-4823 · Cited by 1
“Quantitative PCR in sepsis patients blood showed that overexpression of GILZ transcript variant 1 correlated with poor prognosis, so corticosteroid treatment may not be suitable for speci c GILZ subgroups of sepsis patients.”
Another Step in Understanding Glucocorticoid Resistance in Critical Illness*
Branco, R. G., Garcia, P. C. R., & Tasker, R. C. (2015) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000421 · Cited by 1
Endocrine Responses to Critical Illness
Gunst, J., Boonen, E., & den Berghe, G. V. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch3
Angstwurm, M. (2015) · Springer eBooks · doi:10.1007/978-3-662-45148-9_18
Critical illness-related corticosteroid insufficiency
Burkitt, J. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-76469-8.00090-3
Kim, J. H. (2025) · Archives of Pediatric Critical Care · doi:10.32990/apcc.2025.00031
Pavlik, T. I., Kostukova, N. M., Razvolyaeva, D., Кончеков, Е. М., Kolik, L. V., Gusein-zade, N. G., & Шимановский, Н. Л. (2025) · Medical Sciences · doi:10.3390/medsci13040209
Higher Serum Cortisol is Associated with Delayed Shock Resolution in Septic Shock Patients
Dumrongsukit, S., Charoensri, S., Mulalin, K., & Panitchote, A. (2026) · Journal of Intensive Care Medicine · doi:10.1177/08850666261423897
Adrenal Insufficiency following Septic Shock: A Case Report
Wicksted, K., & Timmons, J. G. (2026) · Biomedicine Hub · doi:10.1159/bmh/aboag001
Jia, Z., Zhao, X., Liu, X., & 李小丽 (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1962609
Metadata
- Authors
- Guerrero, J., Gatica, H. A., Rodríguez, M., Estay, R., & Goecke, I. A.
- Affiliations
- University of Chile (CL)
- Corresponding author
- Goecke, Irmgadt Annelise
- Venue
- Critical Care
- Published
- 2013-06-12
- Volume
- 17
- Issue
- 3
- Pages
- R107-R107
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC4056039
- OpenAlex
- W2069200792
- Cited by
- 71
- References
- 58
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 8 · 2016: 3 · 2015: 5 · 2014: 6 · 2013: 2
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Critical Care (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- sepsis, septic shock, glucocorticoid resistance, glucocorticoid receptor beta, glucocorticoid receptor alpha, peripheral blood mononuclear cells, glucocorticoid sensitivity, T cells, B cells, glucocorticoid therapy
- MeSH terms
- Adult, Aged, Drug Resistance, Female, Gene Expression Regulation, Glucocorticoids, Humans, Male, Middle Aged, Prospective Studies, Receptors, Glucocorticoid, Cohort Studies, Sepsis, K562 Cells, Protein Isoforms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.